|Bid||15.90 x 3200|
|Ask||17.92 x 3100|
|Day's range||16.47 - 17.55|
|52-week range||15.83 - 31.18|
|Beta (5Y monthly)||0.61|
|PE ratio (TTM)||19.92|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The mean of analysts' price targets for Corcept (CORT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CORT vs. ZTS: Which Stock Is the Better Value Option?
A look at the shareholders of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) can tell us which group is most...